Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids.
Biosci Biotechnol Biochem. 2002 Nov;66(11):2491-4. doi: 10.1271/bbb.66.2491.
Biosci Biotechnol Biochem. 2002.
PMID: 12506995
Free article.
Enhancement of developmental competence after in vitro fertilization of porcine oocytes by treatment with ascorbic acid 2-O-alpha-glucoside during in vitro maturation.
Tatemoto H, Ootaki K, Shigeta K, Muto N.
Tatemoto H, et al. Among authors: ootaki k.
Biol Reprod. 2001 Dec;65(6):1800-6. doi: 10.1095/biolreprod65.6.1800.
Biol Reprod. 2001.
PMID: 11717144
Item in Clipboard
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis.
Nakagawa H, Iizuka H, Nemoto O, Shimabe M, Furukawa Y, Kikuta N, Ootaki K.
Nakagawa H, et al. Among authors: ootaki k.
J Dermatol Sci. 2020 Aug;99(2):82-89. doi: 10.1016/j.jdermsci.2020.06.005. Epub 2020 Jun 13.
J Dermatol Sci. 2020.
PMID: 32651105
Clinical Trial.
Item in Clipboard
Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study.
Yamaguchi Y, Takatsu N, Ootaki K, Nakagawa H.
Yamaguchi Y, et al. Among authors: ootaki k.
J Dermatol. 2020 Jun;47(6):569-577. doi: 10.1111/1346-8138.15343. Epub 2020 Apr 10.
J Dermatol. 2020.
PMID: 32275086
Free PMC article.
Clinical Trial.
Item in Clipboard
Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis.
Umezawa Y, Nakagawa H, Niiro H, Ootaki K; Japanese Brodalumab Study Group.
Umezawa Y, et al. Among authors: ootaki k.
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1957-1960. doi: 10.1111/jdv.13785. Epub 2016 Jun 29.
J Eur Acad Dermatol Venereol. 2016.
PMID: 27358210
Item in Clipboard
Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study.
Yamasaki K, Nakagawa H, Kubo Y, Ootaki K; Japanese Brodalumab Study Group.
Yamasaki K, et al. Among authors: ootaki k.
Br J Dermatol. 2017 Mar;176(3):741-751. doi: 10.1111/bjd.14702. Epub 2016 Oct 2.
Br J Dermatol. 2017.
PMID: 27106510
Clinical Trial.
Item in Clipboard
Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study.
Nakagawa H, Niiro H, Ootaki K; Japanese brodalumab study group.
Nakagawa H, et al. Among authors: ootaki k.
J Dermatol Sci. 2016 Jan;81(1):44-52. doi: 10.1016/j.jdermsci.2015.10.009. Epub 2015 Oct 24.
J Dermatol Sci. 2016.
PMID: 26547109
Clinical Trial.
Item in Clipboard
Cite
Cite